Platform Technology

Platform Biotech Models Attract Investor Attention as Drug-Delivery Market Nears $410 Billion

Platform Biotech Models Attract Investor Attention as Drug-Delivery Market Nears $410 Billion

Biotechnology companies are increasingly focusing on platform technologies for drug delivery to maximize existing therapies, with the market projected to reach $410 billion, drawing investor interest to firms like Oncotelic Therapeutics.

June 3, 2026
Oncotelic Therapeutics Highlighted in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation

Oncotelic Therapeutics Highlighted in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation

Oncotelic Therapeutics is featured in a BioMedWire editorial that examines how biotech companies use advanced drug-delivery technologies and AI platforms to enhance therapies, highlighting Oncotelic's Sapu003, Deciparticle, and PDAOAI initiatives.

June 3, 2026